WARSAW, Ind. - Orthopedic implant maker Zimmer Holdings Inc. said Tuesday its second-quarter fell 2 percent on a surge in operating costs as it deals with the ongoing launches of several products.
| ZMH | 69.78 |
The financial results fell short of Wall Street forecasts and shares fell $5.98, or 8.4 percent, to $64.90 in after-hours trading. The stock rose 52 cents to close at $70.88.
The company earned $227.1 million, or 99 cents per share, compared with a profit of $231.5 million, or 97 cents per share, during the same period a year prior. There were about 10 million less shares of common stock outstanding in the most recent quarter.
Revenue rose 11 percent to $1.08 billion from $970.6 million.
Analysts polled by Thomson Financial expected a profit of $1.03 per share on revenue of $1.07 billion.
Sales of knee products rose 15 percent to $467 million while sales of hip products rose 12 percent to $343 million.
Meanwhile, operating expenses rose 18 percent to $508.8 million on higher selling, general and administrative costs.
In a statement, the company said it resumed Zimmer Institute training activities during the quarter, which supports the ongoing launches of several key products.

The above adage is well known by precious-metals investors; in fact I used this quote in one of our monthly reports. I recall how many inquiries ...
The review was scathing. "She cannot sing very well," it said. "She is flat a go...
IN THE HEADLINES McCain caps GOP convention vowing 'change is coming' to Washing...


Professional Website Design For Corporate - Get a Free Quote Today